The two classes diverge with respect to atherothrombotic events: GLP-1RAs modestly reduce myocardial infarction in addition to stroke, whereas the SGLT2i MACE benefit is driven predominantly by reductions in cardiovascular death rather than myocardial infarction [5, 15]
DInc R, Barollo M, Scarpa M, Grillo AR, Brun P, Vettorato MG, et al
BMI Insights: An overwhelming majority of users have obesity
40 Comparing these two independent studies, oral semaglutide at 14 mg/day was similar to 0.5 mg of subcutaneous semaglutide in terms of glycemic and weight effect, as well as adverse events leading to premature treatment discontinuation
Why Resistance Training Helps Break Through GLP-1 Stalls When you're experiencing a plateau on GLP-1 medications, incorporating resistance training into your exercise routine is one of the most effective strategies you can use